Precision Medicine:
Challenges and Opportunities from Regulatory, Clinical and Statistical Perspectives
Date: Sept. 19, 2015 (Saturday)
Location: UMBC Physics 101 and Public Policy 105
University of Maryland, Baltimore County
1000 Hilltop Circle, Baltimore, MD 21250
The inaugural 2015 UMBC-Stanford Workshop features an opening introductory remark by Professor Lai of Stanford on “Clinical Trials and Regulatory Science: Recent Development and New Directions” and two plenary lectures by Dr. Robert Temple of the US Food and Drug Administration on “Enrichment Designs in Precision Medicine” and Dr. Eric Gibson of Novartis on “Precision Medicine: Challenges and Opportunities from Industry Perspective”. Following the plenary talks, a floor panel discussion will be held in late morning. The afternoon program will feature parallel invited and contributed sessions. This one-day workshop at UMBC immediately follows the 2015 FDA-Industry workshop in Washington D.C., providing networking opportunities for registered participants who will be served lunch in addition to coffee breaks.
Objectives: The UMBC-Stanford Workshop series brings together regulators, academic researchers, and industry professionals to explore prominent issues of common concern, particularly those related to clinical development and regulation of biopharmaceutical products.
Target audience: Clinicians, statisticians, regulatory scientists, and other drug development professionals.
Organizing committee: Yi Huang (UMBC) • Nagaraj Neerchal (UMBC) • Bimal Sinha (UMBC) • Tze Lai (Stanford) • Philip Lavori (Stanford) • Ying Lu (Stanford) • Jie Chen (Novartis) • Joseph Heyse (Merck)
Registration: $100 for people registered online (http://med.stanford.edu/biostatistics/events/) before Sep. 14, 2015; $125 afterwards. Check payment is accepted for onsite registration between 8:00 am – 12:00 noon, Sept. 19, 2015.
For more Information:
Please contact Dr. Yi Huang, Department of Mathematics and Statistics, University of Maryland Baltimore County (UMBC), 1000 Hilltop Circle, Baltimore, MD 21250. E-Mail: yihuang@umbc.edu.
------------------------------
Jie Chen
Sr. Global Group Head, BSS
Novartis Pharmaceuticals Company
------------------------------